UnitedHealthcare
Zytiga (abiraterone)
Drugs for Cancer : Drugs for Cancer
  • Prior Authorization: Documented Diagnosis: Yes
    Duration: 12 Month(s)
    Reauthorization Required: Yes

  • Metastatic Castrate-Sensitive Prostate Cancer (mCSPC):
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialty Pharmacy Provider(s): 1 of Avella Specialty Pharmacy;Optum Specialty Pharmacy
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)

    Metastatic Prostate Cancer:
    Duration: 12 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)